ATR-01

About Azitra

Azitra is a clinical-stage biopharmaceutical company focused on creating novel therapeutics for skin diseases through microbial and protein engineering. Its core technology platform includes a library of approximately 1,500 unique bacterial strains, augmented by AI/ML and licensed genetic engineering tools, to develop engineered strains of Staphylococcus epidermidis and therapeutic proteins. The company's pipeline targets high-need conditions like Netherton syndrome, EGFR inhibitor-associated rash, and ichthyosis vulgaris, positioning it at the forefront of the emerging live biotherapeutic product field in dermatology.

Therapeutic Areas